Iron Triangle Partners LP Spring Works Therapeutics, Inc. Transaction History

Iron Triangle Partners LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$23.12 - $31.38 $7.28 Million - $9.88 Million	-314,724 Reduced 67.69%	150,211 $3.47 Million
Q2 2023 Aug 14, 2023	BUY	$23.15 - $32.71 $3.53 Million - $4.98 Million	152,271 Added 48.7%	464,935 $12.2 Million
Q1 2023 May 15, 2023	BUY	$24.97 - $34.05 $7.81 Million - $10.6 Million	312,664 New	312,664 $8.05 Million

238

70M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.34B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Iron Triangle Partners LP, based on Form 13F filings with the SEC.

Stay updated on Iron Triangle Partners LP with notifications on news.